Junli He - 05 Sep 2021 Form 4 Insider Report for Biostage, Inc. (BSTG)

Role
Director
Signature
/s/ Chad Porter, by power of attorney
Issuer symbol
BSTG
Transactions as of
05 Sep 2021
Transactions value $
$0
Form type
4
Filing time
10 Nov 2021, 19:38:01 UTC
Previous filing
10 Nov 2021
Next filing
20 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSTG Stock Option (right to buy) Award $0 +10,895 $0 10,895 05 Sep 2021 Common Stock, par value $0.01 per share 10,895 $2.75 Direct F1
transaction BSTG Stock Option (right to buy) Award $0 +8,727 +80% $0 19,622 05 Sep 2021 Common Stock, par value $0.01 per share 8,727 $2.75 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Stock Option represents the initial equity grant to the Reporting Person upon appointment as a non-employee director of the Issuer, and will vest in four equal installments on December 5, 2021, March 5, 2022, June 5, 2022 and September 5, 2022.
F2 This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, December 5, 2021, March 5, 2022 and June 5, 2022.

Remarks:

This form has been signed under power of attorney.